{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T07:47:41Z","timestamp":1714981661547},"reference-count":11,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/mco.2016.927","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T09:26:38Z","timestamp":1465809998000},"page":"331-332","source":"Crossref","is-referenced-by-count":3,"title":["T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis"],"prefix":"10.3892","volume":"5","author":[{"given":"Rafet","family":"Eren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceyda","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Yoku\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Hilmi","family":"Do\u011fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Suyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"key20180107150346_b1-mco-0-0-927","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J Clin Invest"},{"key":"key20180107150346_b2-mco-0-0-927","author":"Gamal","year":"2011","journal-title":"Classification of Acute Leukemia"},{"key":"key20180107150346_b3-mco-0-0-927","doi-asserted-by":"crossref","first-page":"135186","DOI":"10.1155\/2012\/135186","article-title":"Myeloid antigen expression in childhood acute lymphoblastic leukemia and its relevance for clinical outcome in indonesian ALL-2006 protocol","volume":"2012","author":"Supriyadi","year":"2012","journal-title":"J Oncol"},{"key":"key20180107150346_b4-mco-0-0-927","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.yexmp.2007.08.012","article-title":"Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias","volume":"83","author":"Suggs","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"key20180107150346_b5-mco-0-0-927","first-page":"28","article-title":"Clinical features and treatment outcome of children with myeloid antigen-positive acute lymphoblastic leukemia: A report from the Children's cancer group","volume":"90","author":"Uckun","year":"1997","journal-title":"Blood"},{"key":"key20180107150346_b6-mco-0-0-927","first-page":"ELT26","article-title":"CD56 in T-cell acute lymphoblastic leukaemia: A malignant transformation of an early myeloid-lymphoid progenitor?","volume":"88","author":"Montero","year":"2003","journal-title":"Haematologica"},{"key":"key20180107150346_b7-mco-0-0-927","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3324\/haematol.13543","article-title":"CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy","volume":"94","author":"Fischer","year":"2009","journal-title":"Haematologica"},{"key":"key20180107150346_b8-mco-0-0-927","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the world health organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"key20180107150346_b9-mco-0-0-927","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.V82.3.889.889","article-title":"Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia","volume":"82","author":"Pui","year":"1993","journal-title":"Blood"},{"key":"key20180107150346_b10-mco-0-0-927","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2005-04-1754","article-title":"Adult T-cell acute lymphoblastic leukemia: Biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol","volume":"107","author":"Vitale","year":"2006","journal-title":"Blood"},{"key":"key20180107150346_b11-mco-0-0-927","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10238-009-0067-8","article-title":"Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome","volume":"10","author":"Bhushan","year":"2010","journal-title":"Clin Exp Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2016.927\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T04:55:28Z","timestamp":1600750528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2016.927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,13]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/mco.2016.927"],"URL":"https:\/\/doi.org\/10.3892\/mco.2016.927","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]}}}